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Purpose: To determine the association between daily ambulatory activity patterns and exercise performance in patients
with intermittent claudication.
Methods: One hundred thirty-three patients limited by intermittent claudication participated in this study. Patients were
assessed on their ambulatory activity patterns for 1 week with a small, lightweight step activity monitor attached to the
ankle using elastic velcro straps above the lateral malleolus of the right leg. The step activity monitor recorded the number
of strides taken on a minute-to-minute basis and the time spent ambulating. Patients also were characterized on
ankle-brachial index (ABI), ischemic window (IW) after a treadmill test, as well as initial claudication distance (ICD), and
absolute claudication distance (ACD) during treadmill exercise.
Results: The patient characteristics (mean  SD) were as follows: ABI  0.71  0.23, IW  0.54  0.72 mm
Hg · min · meter1, ICD  236  198 meters, and ACD  424  285 meters. The patients took 3366  1694
strides/day, and were active for 272  103 min/day. The cadence for the 30 highest, consecutive minutes of each day
(15.1  7.2 strides/min) was correlated with ICD (r  0.316, P < .001) and ACD (r  0.471, P < 0.001), and the
cadence for the 60 highest, consecutive minutes of each day (11.1 5.4 strides/min) was correlated with ICD (r 0.290,
P < .01) and ACD (r  0.453, P < .001). Similarly, the cadences for the highest 1, 5, and 20 consecutive minutes, and
the cadence for the 30 highest, nonconsecutive minutes all were correlated with ICD and ACD (P < .05). None of the
ambulatory cadences were correlated with ABI (P > .05) or with ischemic window (P > .05).
Conclusion:Daily ambulatory cadences are associated with severity of intermittent claudication, as measured by ACD and
ICD, but not with peripheral hemodynamic measures. ( J Vasc Surg 2008;48:1238-44.)Peripheral arterial disease (PAD) is prevalent in 16% of
the US population older than 55 years of age, and the
symptom of intermittent claudication is prevalent in 5%.1
Intermittent claudication is ischemic muscular leg pain that
occurs during ambulation when the peripheral circulation is
inadequate to meet the metabolic requirement of the active
leg musculature. Consequently, intermittent claudication
leads to ambulatory dysfunction,2-5 a decline in daily phys-
ical activities,6 and lower health-related quality of life.7 The
lifestyle limitations imposed by intermittent claudication
further compounds poor long-term survival,8-12 as the
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1238mortality risk of sedentary patients with intermittent clau-
dication is higher than their more active counterparts.13
Few studies have objectively quantified physical activity
in patients with PAD.6,14-16 Daily physical activity is lower
in PAD patients than in age-matched controls, and is
associated with the absolute claudication distance (ACD)
during a standardized treadmill test,15 and with 6-minute
walk distance15 in patients limited by intermittent claudi-
cation. However, it is not clear whether patients with worse
exercise performance have lower daily physical activity be-
cause of spending less time in physical activity, because of
engaging in less intense physical activity, or a combination
of both. Decline in physical activity of moderate and high
intensity are particularly noteworthy because this may re-
flect greater difficulty in performing activities of daily living,
and because this increases the risk of mortality in patients
with intermittent claudication.13
The purpose of this study was to determine the associ-
ation between daily ambulatory activity patterns and exer-
cise performance in patients with intermittent claudication.
METHODS
Subjects
Recruitment. Patients between the ages of 50 and 90
years were evaluated in the General Clinical Research Cen-
ter at the University of Oklahoma Health Sciences Center
(HSC). Patients were recruited by referrals from the HSC
vascular clinics and laboratories, as well as by newspaper
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vascular function in those who experience ambulatory leg
pain. The procedures used in this study were approved by
the Institutional Review Boards at the University of Okla-
homa HSC. Written informed consent was obtained from
each subject prior to investigation.
Patient screening. Patients with intermittent claudi-
cation secondary to vascular insufficiency were included in
this study if they met the following criteria: (1) positive test
on the San Diego claudication questionnaire,17 (2) ambu-
lation during a graded treadmill test limited by intermittent
claudication,18 and (3) an ankle-brachial index (ABI) 
0.90.1 Patients were excluded from this study for the
following conditions: (1) absence of PAD (ABI  0.90),
(2) inability to obtain an ABImeasure due to noncompress-
ible vessels, (3) asymptomatic PAD, (4) rest pain PAD, (5)
use of medications indicated for the treatment of intermit-
tent claudication (cilostazol and pentoxifylline) initiated
within 3 months prior to investigation, (6) exercise toler-
ance limited by factors other than leg pain (eg, severe
coronary artery disease, dyspnea, poorly controlled blood
pressure), and (7) active cancer, renal disease, or liver
disease. A total of 133 patients with intermittent claudica-
tion were deemed eligible for this investigation, whereas 17
subjects were ineligible.
Measurements
Medical history. Demographic information, height,
weight, waist and hip circumferences,19 cardiovascular risk
factors, comorbid conditions, claudication history, and a
list of current medications were obtained during a medical
history and physical examination to begin the evaluation.
Gardner treadmill test. Patients performed a pro-
gressive, graded treadmill protocol (2 mph, 0% grade with
2% increase every 2 minutes) until maximal claudication
pain as previously described.18 The initial claudication dis-
tance (ICD), defined as the walking distance at which the
patient first experienced pain, and the absolute claudication
distance (ACD), defined as the walking distance at which
ambulation could not continue due to maximal pain, were
both recorded to quantify the severity of claudication.
Exercise capacity was measured by oxygen uptake at peak
exercise with a Medical Graphics VO2000 metabolic sys-
tem (Medical Graphics Corp, St Paul, Minn). Using these
procedures, the test-retest intraclass reliability coefficient is
R  0.89 for ICD,18 R  0.93 for ACD18, and R  0.88
for peak oxygen uptake.20 Additionally, ABI measures were
obtained from the more severely diseased lower extremity
before and 1, 3, 5, and 7 minutes after each treadmill test as
previously described.18,21 Ankle systolic blood pressure was
measured from the posterior tibial and dorsalis pedis arter-
ies in both legs, and the higher of the two arterial pressures
from the more severely diseased leg was recorded as the
ankle pressure at rest.15,22 Ankle systolic pressure was taken
from the same arterial location during measurements fol-
lowing the treadmill test. The reduction in ankle systolic
blood pressure from the resting baseline value, and its
recovery over time following treadmill exercise was quanti-fied by calculating the area over the curve using the trape-
zoidal rule, referred to as the ischemic window.23 The
ischemic window is a measure of the severity of the ischemic
deficit of exercise.23 Because the ischemic deficit is a func-
tion of both PAD severity as well as the amount of exercise
performed, the ischemic window was divided by ACD to
normalize the ischemic window per meter walked.
Ambulatory activity monitoring. Daily ambulatory
activity was assessed using a small (75  50  20 mm),
lightweight (38 g) step activity monitor (Step Watch 3,
Cyma Inc, Mountlake Terrace, Wash) containing a sensor,
electronics, and a battery inside a completely sealed and
durable polycarbonate case.16 The monitor is a stride
counter that utilizes a microprocessor linked accelerometer
with filtering thresholds for cadence and motion parame-
ters.24 The step activity monitor was programmed by plac-
ing the unit on a USB docking station connected to a
computer with Step Watch 3 Analysis Software. Ambula-
tory activity was measured during 7 consecutive days in
which subjects were instructed to wear the monitor during
waking hours and to remove it before retiring to bed. The
step activity monitor was attached to the right ankle above
the lateral malleolus using elastic velcro straps, and contin-
uously recorded the number of steps taken on a minute-to-
minute basis. Subjects returned the monitor at the end of
the 7-day period, and the data were downloaded into a
subject file stored in the software program. The accuracy of
the step activity monitor exceeds 99% 1% compared with
hand-tallied step counts during a 6-minute walk test per-
formed by a subset of subjects with intermittent claudica-
tion (n  15) and controls (n  15).16 This accuracy is
similar to previous studies, which have reported step count
accuracies ranging from 96% to 99.9% in various clinical
populations.24-28
Variables obtained from the step activity moni-
tor. The step activity monitor records the number of am-
bulatory strides taken per minute for each minute through-
out a 24-hour period. After data from the step activity
monitor is downloaded to a computer, the software pro-
gram displays the number of strides taken each day and the
number of minutes spent ambulating each day. The daily
ambulatory strides and time are further analyzed by the
software program, and are quantified into the following
variables: (1) daily strides taken and time spent ambulating
at low cadence (between 1 and 15 strides/min), medium
cadence (between 16 and 30 strides/min), and high ca-
dence (more than 30 strides/min), (2) daily sedentary time
in which no ambulation occurs (0 strides/min), (3) maxi-
mum cadence for 60, 30, 20, and 5 continuous minutes of
ambulation each day, (4) maximum cadence for 1 minute
of ambulation each day (ie, the minute having the single
highest cadence value each day), and (5) peak activity index
obtained by ranking all minutes of the day according to
cadence, and then taking the highest 30 values.
These outcomemeasures are recorded and averaged for
each day, and then the daily averages are averaged over the
seven-day monitoring period. The maximum 60-minute,
maximum 30-minute, and maximum 20-minute cadences
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vide information on whether individuals meet the tradi-
tional recommended guidelines to improve cardiopulmo-
nary fitness by exercising between 20 to 60 minutes at
moderate-to-high endurance exercise three or more times
per week.29 The average cadence obtained for the maxi-
mum 60-minute, maximum 30-minute, and maximum 20-
minute measures gives an indication of whether individuals
ambulate at a sufficient rate over these durations to elicit a
potential training stimulus to improve cardiopulmonary
fitness. The peak activity index cadence is intended to
provide information on whether individuals meet the
newer recommended guidelines to attain health benefits by
accumulating 30 minutes or more of moderate-intensity
physical activity on most, preferably all, days of the week.29
The newer guidelines emphasize that physical activity does
not need to be done continuously, but rather can be
accumulated throughout the day in an intermittent man-
ner. The average cadence obtained for the peak activity
index indicates whether individuals intermittently ambulate
at a sufficient rate for 30 minutes during the day to elicit
potential health benefits. In contrast to these endurance-
related measures, the maximum 5-minute and maximum
1-minute cadences calculated from the software program
are more characteristic of short-duration activity, and may
reflect the ability of individuals to ambulate quickly. The
cadences attained during these short ambulatory durations
are not a reflection of cardiopulmonary function, but rather
they may be indicators of functioning of the lower extrem-
ities. In subjects with intermittent claudication, the test-
retest intraclass reliability coefficient for the measurement
of total daily strides and total daily minutes of activity over
the 7-day period are R 0.87 and R 0.85, respectively.16
The intraclass reliability coefficients for the remaining vari-
ables pertaining to daily ambulatory strides, daily ambula-
tory durations, and daily ambulatory cadences range from
R  0.83 to R  0.94.
Statistical analyses
Partial correlation coefficients were calculated to deter-
mine the association between daily ambulatory activity
patterns and exercise performance in patients with intermit-
tent claudication, adjusting for age, weight, body mass
index (BMI), sex, race, current smoking, diabetes, hyper-
tension, dyslipidemia, abdominal obesity, obesity, coronary
artery disease, chronic obstructive pulmonary disease, and
congestive heart failure. It was noted that the distributions
of some variables were asymmetric. To minimize the pos-
sible distorting effect of extreme values, both Pearson and
Spearman partial correlation coefficients were computed
for each pair of variables of interest, with Spearman used
only if the two estimates differed by more than 0.1. Re-
ported P values are for individual tests. All analyses were
performed using the SPSS-PC statistical package (SPSS Inc,
Chicago, Ill). Statistical significance was set at P  .05.
Measurements are presented as means  standard devia-
tions.RESULTS
The clinical characteristics of the patients with intermit-
tent claudication are shown in Table I. The group consisted
of a similar proportion of men and women, as well as
Caucasians and African Americans. The ABI, ICD, ACD,
and cardiovascular risk factors are typical for those with
intermittent claudication.
The ambulatory strides recorded during the 1-week
monitoring period, and their association with exercise per-
formance in patients with intermittent claudication is
shown in Table II. On average, the patients took 3366 daily
strides in which 35% were at low cadence, 44% were at
medium cadence, and 21% were at high cadence. The total
daily strides were positively correlated with ACD (P 
.001) and negatively correlated with ischemic window (P
.05). The daily strides at low cadence were negatively
correlated with ischemic window (P  .05), and the per-
centage of strides at low cadence was negatively associated
with ICD (P .05) and ACD (P .001). The daily strides
at medium cadence, high cadence, and the percentage of
strides at high cadence were all positively associated with
ACD (P  .001). None of the stride variables were corre-
lated with ABI (P  .05).
The ambulatory durations and their associations with
exercise performance in patients with intermittent claudi-
cation are shown in Table III. On average, the patients were
active for 272 minutes each day, in which 69% of the time
was spent at low cadence, 25% was at medium cadence, and
6% was at high cadence. Total activity time was positively
correlated with ACD (P  .05) and negatively correlated
Table I. Clinical characteristics of 133 peripheral arterial
disease patients with intermittent claudication
Variables Values
Age (y) 67 (10)
Weight (kg) 82.5 (18.9)
Body mass index (kg/m2) 29.2 (6.6)
Ankle-brachial index 0.71 (0.23)
Ischemic window (mm Hg · min · meter1) 0.54 (0.72)
ICD (meters) 236 (198)
ACD (meters) 424 (285)
Peak oxygen uptake (ml · kg1 · min1) 12.6 (4.0)
Sex (% men) 50
Race (% Caucasian) 49
Coronary artery disease (% yes) 42
Chronic obstructive pulmonary disease (% yes) 26
Congestive heart failure (% yes) 11
Current smoking (% yes) 32
Diabetes (% yes) 29
Hypertension (% yes) 79
Dyslipidemia (% yes) 79
Abdominal obesity (% yes) 65
Obesity (% yes) 39
ACD, Absolute claudication distance; ICD, initial claudication distance.
Values are means (SD) or percentages.
Obesity was defined as having a body mass index  30 kg/m2. Abdominal
obesity was defined as having a waist circumference  102 cm for men
and  88 cm for women.with ischemic window (P .05). The percentage of activity
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(P  .05) and ACD (P  .001). The activity time at
medium cadence was positively correlated with ischemic
window (P .05) and ACD (P .01), and the percentage
of activity time at medium cadence was positively correlated
with ICD (P .05) and ACD (P .01). The activity time
at high cadence and the percentage of activity at high
cadence were positively associated with ACD (P  .001).
None of the activity durations were correlated with ABI
(P  .05).
The ambulatory cadences and their associations with
exercise performance in patients with intermittent claudi-
cation are shown in Table IV. The average daily cadence
was 12.2 strides per minute, ranging between 11.1 strides
per minute for the most active 60 consecutive minutes of
each day to 46.1 strides per minute for the most active
single minute of each day. The cadence for the 30 highest,
nonconsecutive minutes of each day (peak activity index)
was 28.3 strides per minute. All of the cadence variables
were positively associated with ICD (P  .05) and ACD
Table II. Ambulatory strides recorded during a 1-week m
performance measures in patients with intermittent claudic
Variables Mean (SD)
Strides at low cadence (strides/d) 1177 (461)
Strides at medium cadence (strides/d) 1477 (940)
Strides at high cadence (strides/d) 712 (779)
Total strides (strides/d) 3366 (1694
Percentage of strides at low cadence (%) 35 (11)
Percentage of strides at medium cadence (%) 44 (10)
Percentage of strides at high cadence (%) 21 (13)
ABI, Ankle-brachial index; IW, ischemic window; ACD, absolute claudicat
r Pearson partial correlation coefficients or Spearman partial correlation co
sex, race, current smoking, diabetes, hypertension, dyslipidemia, abdomina
and congestive heart failure.
aP  .05.
bP  .01.
cP  .001.
Table III. Ambulatory durations recorded during a 1-wee
performance measures in patients with intermittent claudic
Variables Mean (
Time at low cadence (min/d) 188 (7
Time at medium cadence (min/d) 67 (3
Time at high cadence (min/d) 17 (1
Total activity time (min/d) 272 (1
Percentage of activity time at low cadence (%) 69 (1
Percentage of activity time at medium cadence (%) 25 (8
Percentage of activity time at high cadence (%) 6 (6
ABI, Ankle-brachial index; IW, ischemic window; ACD, absolute claudicat
r Pearson partial correlation coefficients or Spearman partial correlation co
sex, race, current smoking, diabetes, hypertension, dyslipidemia, abdomina
and congestive heart failure.
aP  .05.
bP  .01.
cP  .001.(P  .001). None of the ambulatory cadences were corre-lated with ABI (P  .05) or with ischemic window (P 
.05).
DISCUSSION
The major findings of this investigation are that (1)
daily ambulatory strides, durations, and cadences are asso-
ciated with ACD, (2) ambulatory cadences are more closely
correlated with ACD and ICD than are ambulatory strides
or ambulatory duration, and (3) daily ambulatory strides,
durations, and cadences are not associated with ABI or with
ischemic window.
The patients in this investigation ambulated for an
average of 272 minutes each day and took an average of
3366 strides, which are 13% and 20% lower than in controls
of similar age.16 Both the total time and total strides during
ambulation were positively associated with ACD, indicat-
ing that patients with milder intermittent claudication am-
bulate more in a community-based setting than patients
with more severe symptoms. This observation is supported
by previous investigations in our laboratory, which found
ring period and their associations with exercise
ABI (r) IW (r) ICD (r) ACD (r)
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leisure-time physical activity subjectively measured with a
questionnaire.6,30 Collectively, these results indicate that
the total daily physical activity is associated with ACD in
patients with intermittent claudication.
A novel finding in the present investigation is that the
cadence of ambulation is a stronger correlate of ICD and
ACD than are measures of total physical activity (eg, total
daily strides and total daily activity time). This suggests that
ambulatory cadence in a community-based setting is the
aspect of ambulation that is most associated with the sever-
ity of intermittent claudication. In particular, ambulatory
cadence was more closely related to ACD than to ICD,
suggesting that the ability or willingness to walk tomaximal
claudication pain (ie, ACD) is partially explained by activity
level as well as by the severity of vascular insufficiency,
whereas ICD may be more related to the latter. On closer
examination of the cadence data, the maximum cadence for
30-minute and 60-minute durations throughout the day
were the highest correlates of ACD. Continuous ambula-
tion for 30 minutes to 1 hour reflects endurance-related
activities, and suggests that patients with lower ACD values
must slow their cadence to complete ambulatory activities
of prolonged durations compared with patients with higher
ACD values.
The slower rate of continuous ambulation in patients
with lower ACD compared with those with higher ACD
may be an adopted strategy to delay the onset and devel-
opment of intermittent claudication during prolonged,
continuous ambulation. For example, patients with severe
intermittent claudicationmay select a slow ambulatory pace
while walking in the community setting as a strategy to
avoid experiencing the onset of claudication. This is also
evident for discontinuous ambulation, as peak activity in-
dex was directly correlated with ACD. Peak activity index
represents the average stride rate for the highest 30minutes
of each day, regardless of whether they occurred continu-
ously or discontinuously. Thus, patients with severe inter-
Table IV. Ambulatory cadences recorded during a 1-week
performance measures in patients with intermittent claudic
Variables Mean (SD)
Maximum 1-min cadence (strides/min) 46.1 (5.4)
Maximum 5-min cadence (strides/min) 29.5 (8.1)
Maximum 20-min cadence (strides/min) 18.6 (10.9)
Maximum 30-min cadence (strides/min) 15.1 (7.2)
Maximum 60-min cadence (strides/min) 11.1 (5.4)
Peak activity index (strides/min) 28.3 (7.3)
Average cadence (strides/min) 12.2 (3.2)
ABI, Ankle-brachial index; IW, ischemic window; ACD, absolute claudicat
r Pearson partial correlation coefficients or Spearman partial correlation co
sex, race, current smoking, diabetes, hypertension, dyslipidemia, abdomina
and congestive heart failure.
aP  .05.
bP  .01.
cP  .001.mittent claudication may try to avoid experiencing claudi-cation by ambulating slowly even during prolonged,
intermittent ambulation.
Patients with shorter ACD also had patterns of slower
ambulation for relatively short durations, as the maximum
cadence attained for 1-minute and 5-minute durations
throughout the day were associated with ACD. These
slower ambulatory cadences, especially for the maximum
1-minute duration, suggest that ambulatory pattern is al-
tered even at the initiation of ambulation in those with
shorter ACD. This agrees with our previous report that gait
is altered in patients with intermittent claudication that
favors stability over speed of ambulation even during pain-
free ambulation.31 Another plausible explanation for the
association between ACD and ambulatory cadence of short
duration is that greater muscle weakness is associated with a
progression of intermittent claudication. Isokinetic and iso-
metric strength of the gastrocnemius, tibialis anterior, and
dorsiflexor muscle groups are lower in patients with intermit-
tent claudication than in controls, and are lower in the more
symptomatic leg.32-34 Thus, impaired strength of the lower
extremities as well as altered gait may account for the decline
in community-based, short-duration ambulation in patients
with severe intermittent claudication.
Although ambulatory cadences are associated with
ACD, they are not associated with either ABI or ischemic
window. These results suggest that community-based am-
bulatory cadences are primarily a function of the severity of
intermittent claudication. Although poor ABI and ischemic
window values are characteristic of patients with PAD and
intermittent claudication, the lack of association between
vascular measures and ambulatory cadences indicates that
the severity of intermittent claudication is a better correlate
of the paces performed during daily ambulation. ABI is not
a strong predictor of ICD and ACD,4 suggesting that
factors other than vascular insufficiency also are related to
claudication distance and ambulation. These factors may
include cardiopulmonary function,35 walking economy,36
muscle mass,37 muscle strength,32 ability of muscle to
nitoring period and their associations with exercise
ABI (r) IW (r) ICD (r) ACD (r)
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tance; ICD, initial claudication distance.
nts (indicated in italicized print), adjusting for age, weight, bodymass index,
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ation
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l obesiextract oxygen,38 obesity,4 and metabolic syndrome.39
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cadence is in disagreement with previous reports showing
that ABI is related to self-reported leisure-time physical
activity,30 monitored physical activity using an accelerom-
eter,6,14,40 and energy expenditure of physical activity with
the doubly-labeled water technique.15 The physical activity
measures obtained with the accelerometer and with the
doubly-labeled water technique are characteristic of the
total amount of physical activity performed (ie, ambulatory
and nonambulatory), which is distinct from the cadence (ie,
intensity) at which ambulation is performed. One of the
advantages of the step activity monitor is that is can distin-
guish between the two, and the results from this trial
suggest that ambulatory cadence throughout daily activities
is more associated with symptoms than with ABI.
There are several limitations to this study. The correla-
tions calculated from this cross-sectional design does not
allow causality be established, as it is possible that daily
ambulation influences ACD or vice versa. A longitudinal
follow-up study is necessary to better understand the cau-
sality of this relationship in patients with intermittent clau-
dication. A second limitation is that it is possible patients
did not wear the step activity monitor during portions of
their waking hours, thereby resulting in an underestimate
of daily ambulation. We believe that this possibility is
unlikely because long durations in which no active minutes
were recorded during daytime hours were rarely evident
from the software graphs depicting the number of strides
taken on a minute-to-minute basis. Even during several
hours of being sedentary, a few minutes in which some
strides occurred were typically evident, indicating that the
step activity monitor had not been removed. Another lim-
itation is that the type of sedentary activity which took place
during nonactiveminutes cannot be determined by the step
activity monitor. Consequently, it is not possible to quan-
tify the time spent in various sedentary activities such as
watching television, taking naps, and sitting while eating.
Furthermore, the step activity monitor does not quantify
nonambulatory physical activity, and therefore, it underes-
timates the total amount of daily physical activity accom-
plished to some extent. The present findings are also lim-
ited to PAD patients with intermittent claudication and
may not be generalized to patients with less severe and
more severe symptoms. However, subjects with intermit-
tent claudication had a good proportion of women and
African Americans, and they had typical risk factors for
PAD, including smoking, diabetes, hypertension, dyslipi-
demia, and obesity. Thus, the findings of the present study
are generalizable to the majority of subjects with intermit-
tent claudication who typically have numerous comorbid
conditions.
We conclude that daily ambulatory cadences are asso-
ciated with the severity of intermittent claudication, as
measured by ACD and ICD, but not with peripheral
hemodynamic measures. Future trials should examine
whether daily ambulatory cadences of patients with inter-
mittent claudication change during long-term follow-upand in response to interventions designed to improve symp-
toms.
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